282 related articles for article (PubMed ID: 24935182)
1. Effects of melatonin derivatives on human malaria parasite Plasmodium falciparum.
Srinivasan V; Zakaria R; Mohamed M; Saleh RM
Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(2):102-8. PubMed ID: 24935182
[TBL] [Abstract][Full Text] [Related]
2. Melatonin effects on Plasmodium life cycle: new avenues for therapeutic approach.
Srinivasan V; Ahmad AH; Mohamed M; Zakaria R
Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):139-47. PubMed ID: 22537380
[TBL] [Abstract][Full Text] [Related]
3. Malaria: therapeutic implications of melatonin.
Srinivasan V; Spence DW; Moscovitch A; Pandi-Perumal SR; Trakht I; Brown GM; Cardinali DP
J Pineal Res; 2010 Jan; 48(1):1-8. PubMed ID: 20025640
[TBL] [Abstract][Full Text] [Related]
4. Melatonin action in Plasmodium infection: Searching for molecules that modulate the asexual cycle as a strategy to impair the parasite cycle.
Pereira PHS; Garcia CRS
J Pineal Res; 2021 Jan; 70(1):e12700. PubMed ID: 33025644
[TBL] [Abstract][Full Text] [Related]
5. Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum.
Schuck DC; Jordão AK; Nakabashi M; Cunha AC; Ferreira VF; Garcia CR
Eur J Med Chem; 2014 May; 78():375-82. PubMed ID: 24699367
[TBL] [Abstract][Full Text] [Related]
6. The PfNF-YB transcription factor is a downstream target of melatonin and cAMP signalling in the human malaria parasite Plasmodium falciparum.
Lima WR; Moraes M; Alves E; Azevedo MF; Passos DO; Garcia CR
J Pineal Res; 2013 Mar; 54(2):145-53. PubMed ID: 22804732
[TBL] [Abstract][Full Text] [Related]
7. The Plasmodium falciparum eIK1 kinase (PfeIK1) is central for melatonin synchronization in the human malaria parasite. Melatotosil blocks melatonin action on parasite cell cycle.
Dias BKM; Nakabashi M; Alves MRR; Portella DP; Dos Santos BM; Costa da Silva Almeida F; Ribeiro RY; Schuck DC; Jordão AK; Garcia CRS
J Pineal Res; 2020 Oct; 69(3):e12685. PubMed ID: 32702775
[TBL] [Abstract][Full Text] [Related]
8. An interplay between 2 signaling pathways: melatonin-cAMP and IP3-Ca2+ signaling pathways control intraerythrocytic development of the malaria parasite Plasmodium falciparum.
Furuyama W; Enomoto M; Mossaad E; Kawai S; Mikoshiba K; Kawazu S
Biochem Biophys Res Commun; 2014 Mar; 446(1):125-31. PubMed ID: 24607908
[TBL] [Abstract][Full Text] [Related]
9. Malaria, anti malarial drugs and the role of melatonin.
Srinivasan V; Mohamed M; Zakaria R; Ahmad AH
Infect Disord Drug Targets; 2012 Oct; 12(5):371-9. PubMed ID: 23082960
[TBL] [Abstract][Full Text] [Related]
10. Decoding the Role of Melatonin Structure on
Mallaupoma LRC; Dias BKM; Singh MK; Honorio RI; Nakabashi M; Kisukuri CM; Paixão MW; Garcia CRS
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625565
[TBL] [Abstract][Full Text] [Related]
11. Human malarial parasite, Plasmodium falciparum, displays capacitative calcium entry: 2-aminoethyl diphenylborinate blocks the signal transduction pathway of melatonin action on the P. falciparum cell cycle.
Beraldo FH; Mikoshiba K; Garcia CR
J Pineal Res; 2007 Nov; 43(4):360-4. PubMed ID: 17910604
[TBL] [Abstract][Full Text] [Related]
12. Role of Melatonin in the Synchronization of Asexual Forms in the Parasite
Singh MK; Dias BKM; Garcia CRS
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32867164
[TBL] [Abstract][Full Text] [Related]
13. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
Tuteja R
FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
[TBL] [Abstract][Full Text] [Related]
14. Melatonin and IP3-induced Ca2+ release from intracellular stores in the malaria parasite Plasmodium falciparum within infected red blood cells.
Alves E; Bartlett PJ; Garcia CR; Thomas AP
J Biol Chem; 2011 Feb; 286(7):5905-12. PubMed ID: 21149448
[TBL] [Abstract][Full Text] [Related]
15. Blocking IP
Pecenin MF; Borges-Pereira L; Levano-Garcia J; Budu A; Alves E; Mikoshiba K; Thomas A; Garcia CRS
Cell Calcium; 2018 Jun; 72():81-90. PubMed ID: 29748136
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
Qidwai T; Khan F
Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
[TBL] [Abstract][Full Text] [Related]
17. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.
Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR
Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in antimalarial compounds and their patents.
Mital A
Curr Med Chem; 2007; 14(7):759-73. PubMed ID: 17346161
[TBL] [Abstract][Full Text] [Related]
19. Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy.
Watkins WM; Woodrow C; Marsh K
Am J Trop Med Hyg; 1993 Jul; 49(1):106-12. PubMed ID: 8352382
[TBL] [Abstract][Full Text] [Related]
20. Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors.
Hempelmann E
Parasitol Res; 2007 Mar; 100(4):671-6. PubMed ID: 17111179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
